Skip to main content

Civilization Ventures — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

50
Companies
$1.2B
Total invested
$24.4M
Avg. check
31
Industries
Health Care 15Biotechnology 14Life Science 6Therapeutics 4Medical 4Pharmaceutical 4+25 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 50
R-Zero
February 2023

Smart building solutions that automates building and workforce efficiencies, to maximize the ROI of your real estate portfolio.

Energy Efficiency · San Francisco$105.0M Series C
Wyndly
February 2023

Wyndly offers personalized prescription treatment and online care.

Health Care · New York$2.0M Seed
evonetix
February 2023

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Biopharma · Little Chesterford$24.1M Series B
Infinimmune
December 2022

Infinimmune operates as a biotechnology company.

Biotechnology · San Francisco$12.0M Seed
Ulab Systems
September 2022

Ulab Systems develops a breakthrough software technology for digital dental treatment planning.

Consumer Software · Memphis$90.9M Venture - Series Unknown
Klivo
March 2022

Klivo offers treatments for chronic diseases.

Consulting · São Paulo$8.8M Series A
Antheia
January 2026

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

Biotechnology · Menlo Park$24.0M Series C
SyntaxBio
December 2025

SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.

Biotechnology · Chicago$856K Grant
Curve Biosciences
October 2025

Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.

Biotechnology · Mountain View$40.0M Series A
OxCan
January 2025

OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.

Biotechnology · Oxford$11.0M Series A
Aikium Inc.
November 2024

Deep Learning x Synthetic Biology for Novel Protein Therapeutics

Biopharma · Berkeley$1.5M Pre-Seed
Integrated Biosciences
October 2024

Integrated Biosciences develops next-generation therapeutics.

Biopharma · Redwood City$17.2M Seed
Foresight Diagnostics
July 2024

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

Biotechnology · Denver$33.0M Series B
Insamo
April 2024

Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.

Biotechnology · BerkeleyNon Equity Assistance
Fluent BioSciences
March 2024

Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.

Biotechnology · WatertownGrant
Aperiam Bio
November 2023

Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.

Biotechnology · Austin$9.0M Seed
Rocket Pharmaceuticals
September 2023

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

Biotechnology · Cranbury$175.0M Post Ipo Equity
Range Biotechnologies
June 2023

Range Biotechnologies is creating tools to enable personalized health through translational proteomics.

Biotechnology · San Carlos$5.2M Seed
Alveo Technologies
March 2021

Alveo is a pre-clinical stage medical diagnostics company .

Health Care · Alameda$16.0M Series Unknown
Gali Health
December 2020

AI-powered mobile personal health assistant

Artificial Intelligence (AI) · San FranciscoSeed
Kit
November 2020

Kit is an online seller of consumer products.

Communities · San FranciscoSeed
Singular Bio
January 2019

Singular Bio is a privately held company developing single molecule detection technology.

Biotechnology · San Francisco$6.6M Series Unknown

Where Civilization Ventures invests

Health Care15
Biotechnology14
Life Science6
Therapeutics4
Medical4
Pharmaceutical4

About Civilization Ventures's portfolio

How many companies has Civilization Ventures invested in?▸

Civilization Ventures has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Civilization Ventures invest in?▸

Civilization Ventures's top investment sectors include Health Care, Biotechnology, Life Science, Therapeutics, Medical. The firm invests across 31 different industry categories.

What is Civilization Ventures's largest investment?▸

Among tracked funding rounds, Rocket Pharmaceuticals received $175.0M in a Post Ipo Equity round. Civilization Ventures's total known invested capital is $1.2B.

What is the average investment size for Civilization Ventures?▸

Civilization Ventures's average investment size is $24.4M across its portfolio of 50 companies.

What are Civilization Ventures's most recent investments?▸

Recent Civilization Ventures portfolio additions include R-Zero, Wyndly, evonetix, Infinimmune, Ulab Systems. These companies were founded in 2020 or later.

Reach the founders behind these 50 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →